Download PDF
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2017; 04(04): S38-S44
DOI: 10.4103/2348-0548.199947
Conference Proceeding
Thieme Medical and Scientific Publishers Private Ltd.

Cardiovascular manifestations of subarachnoid haemorrhage

Sethuraman Manikandan
1   Professor and Head, Divison of Neuroanesthesia and Neurocritical Care, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India
› Author Affiliations
Further Information

Publication History

Publication Date:
08 May 2018 (online)

   Permissions and Reprints

Abstract

Subarachnoid haemorrhage (SAH) is one of the devastating conditions, especially the aneurysmal bleed which has high mortality as well as morbidity. The mortality and morbidity caused by SAH have been recognised to be caused by both neurological and systemic causes. The alterations in systemic and other organ damage could cause death in up to 40% of SAH patients. Among the systemic manifestations, cardiovascular and respiratory complications increase hospitalisation and worsen the outcome. The main pathophysiological mechanism is the increased sympathetic activation causing myocardial necrosis. Various cardiovascular manifestations range from electrocardiogram changes to myocardial ischaemia, cardiac failure and arrhythmias. This review deals with the cardiac manifestations in SAH patients.

Keywords

Cardiac enzymes - electrocardiographic changes - neurogenic stunned myocardium - subarachnoid haemorrhage
 

  • REFERENCES

  • 1 Ingall T, Asplund K, Mähönen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000; 31: 1054-61
    CrossrefPubMedGoogle Scholar
  • 2 Kassell NF, Torner JC, Haley Jr. EC, Jane JA, Adams HP, Kongable GL. The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 1990; 73: 18-36
    CrossrefPubMedGoogle Scholar
  • 3 Solenski NJ, Haley Jr. EC, Kassell NF, Kongable G, Germanson T, Truskowski L. et al. Medical complications of aneurysmal subarachnoid hemorrhage: A report of the multicenter, cooperative aneurysm study. Participants of the multicenter cooperative aneurysm study. Crit Care Med 1995; 23: 1007-17
    CrossrefPubMedGoogle Scholar
  • 4 Gruber A, Reinprecht A, Illievich UM, Fitzgerald R, Dietrich W, Czech T. et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 1999; 27: 505-14
    CrossrefPubMedGoogle Scholar
  • 5 Doshi R, Neil-Dwyer G. A clinicopathological study of patients following a subarachnoid hemorrhage. J Neurosurg 1980; 52: 295-301
    CrossrefPubMedGoogle Scholar
  • 6 Doshi R, Neil-Dwyer G. Hypothalamic and myocardial lesions after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1977; 40: 821-6
    CrossrefPubMedGoogle Scholar
  • 7 Masuda T, Sato K, Yamamoto S, Matsuyama N, Shimohama T, Matsunaga A. et al. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 2002; 33: 1671-6
    CrossrefPubMedGoogle Scholar
  • 8 Naredi S, Lambert G, Eden E, Zall S, Runnerstam M, Rydenhag B. et al. Increased sympathetic nervous activity in patients with non-traumatic subarachnoid hemorrhage. Stroke 2000; 31: 901-6
    CrossrefPubMedGoogle Scholar
  • 9 Uchida Y, Egami H, Uchida Y, Sakurai T, Kanai M, Shirai S. et al. Possible participation of endothelial cell apoptosis of coronary microvessels in the genesis of takotsubo cardiomyopathy. Clin Cardiol 2010; 33: 371-7
    CrossrefPubMedGoogle Scholar
  • 10 Mann DL, Kent RL, Parsons B, Cooper 4th G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992; 85: 790-804
    CrossrefPubMedGoogle Scholar
  • 11 van der Bilt IA, Vendeville JP, van de Hoef TP, Begieneman MP, Lagrand WK, Kros JM. et al. Myocarditis in patients with subarachnoid hemorrhage: A histopathologic study. J Crit Care 2016; 32: 196-200
    CrossrefPubMedGoogle Scholar
  • 12 Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE. et al. Aneurysmal subarachnoid hemorrhage and neuroinflammation: A comprehensive review. Int J Mol Sci 2016; 17: 497
    CrossrefPubMedGoogle Scholar
  • 13 Brouwers PJ, Wijdicks EF, Hasan D, Vermeulen M, Wever EF, Frericks H. et al. Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage. Stroke 1989; 20: 1162-7
    CrossrefPubMedGoogle Scholar
  • 14 Zaroff JG, Rordorf GA, Newell JB, Ogilvy CS, Levinson JR. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery 1999; 44: 34-9
    CrossrefPubMedGoogle Scholar
  • 15 Sommargren CE, Zaroff JG, Banki N, Drew BJ. Electrocardiographic repolarization abnormalities in subarachnoid hemorrhage. J Electrocardiol 2002; 35 Suppl 257-62
    CrossrefPubMedGoogle Scholar
  • 16 Burch GE, Meyers R, Abildskov JA. A new electrocardiographic pattern observed in cerebrovascular accidents. Circulation 1954; 9: 719-23
    CrossrefPubMedGoogle Scholar
  • 17 Katsanos AH, Korantzopoulos P, Tsivgoulis G, Kyritsis AP, Kosmidou M, Giannopoulos S. Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesions. Int J Cardiol 2013; 167: 328-34
    CrossrefPubMedGoogle Scholar
  • 18 Sakr YL, Lim N, Amaral AC, Ghosn I, Carvalho FB, Renard M. et al. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol 2004; 96: 369-73
    CrossrefPubMedGoogle Scholar
  • 19 Mayer SA, LiMandri G, Sherman D, Lennihan L, Fink ME, Solomon RA. et al. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg 1995; 83: 889-96
    CrossrefPubMedGoogle Scholar
  • 20 Junttila E, Vaara M, Koskenkari J, Ohtonen P, Karttunen A, Raatikainen P. et al. Repolarization abnormalities in patients with subarachnoid and intracerebral hemorrhage: Predisposing factors and association with outcome. Anesth Analg 2013; 116: 190-7
    CrossrefPubMedGoogle Scholar
  • 21 Coghlan LA, Hindman BJ, Bayman EO, Banki NM, Gelb AW, Todd MM. et al. Independent associations between electrocardiographic abnormalities and outcomes in patients with aneurysmal subarachnoid hemorrhage: Findings from the intraoperative hypothermia aneurysm surgery trial. Stroke 2009; 40: 412-8
    CrossrefPubMedGoogle Scholar
  • 22 Chen WL, Huang CH, Chen JH, Tai HC, Chang SH, Wang YC. ECG abnormalities predict neurogenic pulmonary edema in patients with subarachnoid hemorrhage. Am J Emerg Med 2016; 34: 79-82
    CrossrefPubMedGoogle Scholar
  • 23 Schuiling WJ, Algra A, de Weerd AW, Leemans P, Rinkel GJ. ECG abnormalities in predicting secondary cerebral ischemia after subarachnoid haemorrhage. Acta Neurochir (Wien) 2006; 148: 853-8
    CrossrefPubMedGoogle Scholar
  • 24 Ibrahim GM, Macdonald RL. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2012; 43: 2102-7
    CrossrefPubMedGoogle Scholar
  • 25 Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: An echocardiographic study. J Am Coll Cardiol 1988; 12: 600-5
    CrossrefPubMedGoogle Scholar
  • 26 Zaroff JG, Rordorf GA, Ogilvy CS, Picard MH. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: Evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr 2000; 13: 774-9
    CrossrefPubMedGoogle Scholar
  • 27 Davies KR, Gelb AW, Manninen PH, Boughner DR, Bisnaire D. Cardiac function in aneurysmal subarachnoid haemorrhage: A study of electrocardiographic and echocardiographic abnormalities. Br J Anaesth 1991; 67: 58-63
    CrossrefPubMedGoogle Scholar
  • 28 Kothavale A, Banki NM, Kopelnik A, Yarlagadda S, Lawton MT, Ko N. et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care 2006; 4: 199-205
    CrossrefPubMedGoogle Scholar
  • 29 van der Bilt IA, Hasan D, van den Brink RB, Cramer MJ, van der Jagt M, van Kooten F. et al. Time course and risk factors for myocardial dysfunction after aneurysmal subarachnoid hemorrhage. Neurosurgery 2015; 76: 700-5
    CrossrefPubMedGoogle Scholar
  • 30 van der Bilt I, Hasan D, van den Brink R, Cramer MJ, van der Jagt M, van Kooten F. et al. Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: Relationship with outcome. Neurology 2014; 82: 351-8
    CrossrefPubMedGoogle Scholar
  • 31 Cremers CH, van der Bilt IA, van der Schaaf IC, Vergouwen MD, Dankbaar JW, Cramer MJ. et al. Relationship between cardiac dysfunction and cerebral perfusion in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2016; 24: 202-6
    CrossrefPubMedGoogle Scholar
  • 32 Kopelnik A, Fisher L, Miss JC, Banki N, Tung P, Lawton MT. et al. Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care 2005; 3: 132-8
    CrossrefPubMedGoogle Scholar
  • 33 Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008; 118: 397-409
    CrossrefPubMedGoogle Scholar
  • 34 Stevens RD, Nyquist PA. The systemic implications of aneurysmal subarachnoid hemorrhage. J Neurol Sci 2007; 261: 143-56
    CrossrefPubMedGoogle Scholar
  • 35 Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: A new form of acute, reversible heart failure. Circulation 2008; 118: 2754-62
    CrossrefPubMedGoogle Scholar
  • 36 Ancona F, Bertoldi LF, Ruggieri F, Cerri M, Magnoni M, Beretta L. et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: Similar albeit different. Eur Heart J 2016; 37: 2830-2
    CrossrefPubMedGoogle Scholar
  • 37 Bulsara KR, McGirt MJ, Liao L, Villavicencio AT, Borel C, Alexander MJ. et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98: 524-8
    CrossrefPubMedGoogle Scholar
  • 38 Parekh N, Venkatesh B, Cross D, Leditschke A, Atherton J, Miles W. et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000; 36: 1328-35
    CrossrefPubMedGoogle Scholar
  • 39 Deibert E, Barzilai B, Braverman AC, Edwards DF, Aiyagari V, Dacey R. et al. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg 2003; 98: 741-6
    CrossrefPubMedGoogle Scholar
  • 40 Schuiling WJ, Dennesen PJ, Tans JT, Kingma LM, Algra A, Rinkel GJ. Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2005; 76: 1565-9
    CrossrefPubMedGoogle Scholar
  • 41 Tanabe M, Crago EA, Suffoletto MS, Hravnak M, Frangiskakis JM, Kassam AB. et al. Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. Am J Cardiol 2008; 102: 1545-50
    CrossrefPubMedGoogle Scholar
  • 42 Meaudre E, Jego C, Kenane N, Montcriol A, Boret H, Goutorbe P. et al. B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: A prospective study in non-cardiac patients. Crit Care 2009; 13: R76
    CrossrefPubMedGoogle Scholar
  • 43 Oras J, Grivans C, Dalla K, Omerovic E, Rydenhag B, Ricksten SE. et al. High-sensitive troponin T and N-terminal pro B-type natriuretic peptide for early detection of stress-induced cardiomyopathy in patients with subarachnoid hemorrhage. Neurocrit Care 2015; 23: 233-42
    CrossrefPubMedGoogle Scholar